TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.4% | +4.3% | +4.1% | +3.9% | +3.4% | +7.9% | +7.7% | +5.3% | +11.9% | -4.7% | -3.2% | +6.3% | +3.2% | +8.6% | +5.1% | +1.7% | -4.2% | +2.2% | +18.5% | +56.9% | -2.8% | +11.6% | +12.8% | +5.9% | +7.5% | +4.3% | |
| – | -11.2% | -12.0% | -11.1% | -10.3% | +3.6% | +1.0% | -0.9% | -0.4% | +3.9% | -1.5% | +11.4% | +36.4% | +3.3% | +9.5% | +6.3% | +2.8% | +4.4% | -11.2% | +33.0% | +65.2% | -8.8% | +11.3% | +12.4% | +15.1% | +10.4% | +48.0% | |
| – | +18.1% | +15.1% | +11.8% | +9.6% | +3.3% | +10.2% | +10.3% | +6.9% | +13.9% | -5.4% | -6.7% | -2.4% | +3.2% | +8.3% | +4.6% | +1.2% | -7.8% | +8.6% | +12.8% | +53.1% | +0.1% | +11.7% | +13.0% | +1.8% | +6.0% | -18.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +5.3% | +11.9% | -9.5% | -9.7% | +4.2% | +13.2% | +33.7% | -7.4% | +15.4% | +20.4% | +15.3% | +0.0% | -1.9% | |
| – | – | – | – | – | – | – | – | – | – | -20.1% | -4.0% | +26.6% | +0.1% | -44.4% | +10.7% | +30.3% | -4.9% | +1.5% | +14.2% | +34.4% | -9.2% | +1.2% | +12.5% | +5.7% | +4.8% | -1.9% | |
| – | +10.6% | +9.2% | +12.7% | +2.4% | +2.9% | +15.0% | +7.5% | +18.7% | +40.0% | -19.3% | -3.4% | +10.3% | +21.8% | +7.6% | +30.5% | -17.7% | -10.8% | +1.5% | +23.7% | +64.5% | -19.4% | +18.1% | +14.6% | +14.2% | +1.5% | -29.8% | |
| – | +31.9% | +24.4% | +10.5% | +19.6% | +3.7% | +4.6% | +13.8% | -7.7% | -27.6% | +37.1% | -12.6% | -27.8% | -53.8% | +13.7% | -192.8% | – | +19.1% | +55.1% | -15.2% | -51.0% | +407.2% | -9.5% | +6.4% | -56.4% | +60.0% | +67.3% | |
| – | -14.6% | -25.6% | -44.7% | -14.5% | -7.0% | +9.3% | -32.3% | +34.8% | +386.8% | -11.8% | -6.6% | +41.0% | +76.5% | +824.5% | +7.0% | -2.9% | -27.2% | +37.3% | +50.8% | -97.0% | +8,868.4% | -6.4% | -4.5% | -99.1% | +12,824.1% | +176.1% | |
| – | +29.7% | +41.9% | +15.7% | +3.3% | -1.1% | +17.4% | +20.7% | -7.8% | -30.9% | +4.3% | -10.6% | -32.1% | -48.6% | +22.5% | -191.6% | – | +18.9% | +51.5% | -56.3% | -164.0% | – | -17.4% | +24.0% | -85.9% | +231.7% | +57.6% | |
| – | +40.2% | +18.2% | +16.7% | +0.3% | +1.5% | +25.7% | +42.0% | -23.5% | -26.2% | -28.3% | +4.9% | +3.2% | -103.1% | – | -104.9% | – | -24.9% | +9.6% | -146.3% | – | – | – | -19.8% | -257.5% | – | +8.0% | |
| – | +22.8% | +60.5% | +15.3% | +5.0% | -2.7% | +12.9% | +7.2% | +5.9% | -34.1% | +27.0% | -16.8% | -49.9% | +5.7% | -18.7% | -236.7% | – | +43.4% | +62.6% | -41.6% | -59.5% | +749.9% | -38.8% | +37.8% | -54.6% | -25.1% | +88.4% | |
| – | +25.4% | +35.2% | +14.8% | +2.7% | -0.4% | +15.7% | +19.6% | -7.0% | -14.9% | +2.7% | -9.9% | -15.7% | -13.2% | +4.8% | -84.4% | +510.7% | -15.1% | +21.2% | +29.0% | +44.7% | +46.4% | +20.3% | +8.5% | -10.9% | +5.8% | +17.3% |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.